TrialClinical and translational science2026

Safety and Efficacy of HexaBody-DR5/DR5 in Malignant Solid Tumors: Phase 1/2a Results and Translational Insights Into Observed Hepatotoxicity.

Marije B Overdijk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.